I think it's been about 16 months (from memory) that we were told that an application to list on the NASDAQ had been submitted. I know there were accounting standards we had to comply with, and I know the company was advised not to discuss the listing while it was pending.
But at this point in time, I feel the delays are excessive, and my gut tells me there are other undisclosed problems or obstacles. Surely 16 months is long enough for investors to be kept hanging. If there are problems with the process, or further issues of complience, we deserve to know what these are. Investors are hanging back, and the occasional good announcement on sales, marketing, infrastructure, clinical test and patents are having no effect on the price.
How about something, anything at all, on the NASDAQ? Institutional investors would certainly be asking these questions - why can't we?
nasdaq is overdue and an explanation is reqd
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |